Dr. Pavletic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bethesda, MD 20892Phone+1 301-402-4899
Education & Training
University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998- University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1992 - 1995
University of Zagreb Faculty of MedicineClass of 1979
Certifications & Licensure
NE State Medical License 1993 - 2026
Clinical Trials
- Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease Start of enrollment: 2004 Oct 26
- Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System Start of enrollment: 2007 Oct 30
- Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders Start of enrollment: 2009 Aug 25
- Join now to see all
Publications & Presentations
PubMed
- Allogeneic hematopoietic cell transplantation in elderly patients with myelodysplastic syndromes: Considerations and challenges.Eduard Schulz, Steven Z Pavletic, Alain Mina
Seminars in Hematology. 2024-12-01 - Intestinal microbiome and myelodysplastic syndromes: Current state of knowledge and perspectives for future.Marin Simunic, Kathy McGraw, Steven Z Pavletic, Armin Rashidi
Seminars in Hematology. 2024-12-01 - A Call to Arms: Overcoming challenges in Myelodysplastic Syndromes therapy advances.Kathy L McGraw, Peter D Aplan, Steven Z Pavletic
Seminars in Hematology. 2024-12-01
Journal Articles
- Impact of the 2014 NIH Chronic Graft-Versus-Host Disease Scoring Criteria Modifications Assessed in a Large Cohort of Severely Affected PatientsLauren M Curtis, Galen O Joe, Jacqueline W Mays, Ann Berger, Pamela Stratton, Ronald E Gress, Sandra A Mitchell, Steven Z Pavletic, Kristin Baird, Nature
- The eGVHD App Has the Potential to Improve the Accuracy of Graft Versus Host Disease Assessment: A Multicenter Randomized Controlled TrialAnnie Im, Steven Z Pavletic, Haematologica
Abstracts/Posters
- Factors Associated with Subsequent Cancers in Patients with Moderate or Severe Chronic Graft-Versus-Host Disease after Transplant for Hematologic MalignancySteven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)Steven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Clinical Characterization and Cytokine Profile of Fatigue in Patients with Chronic GvhdSteven Z. Pavletic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
GVHD Alliance to Honor Steven Pavletic with the Inaugural Lukas D. Wartman GVHD Achievement AwardFebruary 16th, 2023- The Future of Chronic Graft-Versus-Host DiseaseFebruary 1st, 2021
New Drugs Aim to Disarm the Immune System’s ‘Atomic Bomb’ CellsMarch 5th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
